Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors is a research paper published in European Journal of Medicinal Chemistry (2021). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American University of Sharjah
Grant: 16011101018-P
Fields of Study
MeSH Terms
Keywords